Introduction to the Intellectual Property Appellate Board (IPAB) in India

Before 2003, if you wanted to challenge a decision made by the Registrar of Trade Marks or the Controller of Patents in India, your only option was to knock on the doors of an already overburdened High Court. Cases took years. Technical nuances of patent law were often lost in a generalist judicial system. The Intellectual Property Appellate Board (IPAB) was India’s answer to this growing problem – a specialized tribunal built specifically to handle intellectual property disputes with the depth and speed they deserved. For law students studying patents, understanding the IPAB is foundational, even though the Board no longer exists in its original form. Its legacy continues to shape how IP appeals are structured and argued in India today.

Why India needed a specialized IP appellate body 🔗

India’s intellectual property framework was built over several decades, with the Patents Act, 1970 serving as the primary legislation governing patent rights. Under this Act, appellate jurisdiction – including the power to hear patent appeals and revoke patents – originally rested with the High Courts. While legally sound, this arrangement had a practical problem: High Courts handle an enormous volume and variety of cases. Intellectual property disputes, especially those involving patents, often require judges to evaluate highly technical scientific claims. A generalist bench is not always best equipped for that.

The delays were significant. Cases concerning trademark registrations, patent grants, and revocations piled up in High Courts across the country. As India’s economy opened up post-liberalization and IP filings grew, there was increasing pressure to build a faster, more expert-driven appellate mechanism. The IPAB was conceived as that mechanism – a quasi-judicial tribunal that would combine legal authority with technical expertise in a dedicated forum.

Establishment of the IPAB 🔗

The IPAB was formally constituted on September 15, 2003, through a Gazette Notification (S.O. 1049(E)) issued by the Ministry of Commerce and Industry. It was set up under Section 83 of the Trade Marks Act, 1999, with its headquarters established in Chennai. The choice of Chennai was not incidental – it placed the tribunal in a city with a strong legal tradition and close proximity to southern India’s growing industrial and pharmaceutical sectors, both significant contributors to IP filings.

From its inception, the IPAB had jurisdiction to hear appeals against decisions of the Registrar under the Trade Marks Act, 1999 and the Geographical Indications of Goods (Registration and Protection) Act, 1999. This made it operational for trademark and GI matters from 2003 onward, though commonly referenced as becoming functional for trademarks from around 2002 in some academic contexts due to the legislative groundwork laid before the formal gazette notification.

Beyond its Chennai headquarters, the IPAB was empowered to hold sittings at Mumbai, Delhi, Kolkata, and Ahmedabad – ensuring geographic reach across India’s major commercial and industrial centres.

Extension of jurisdiction to patents: April 2, 2007 🔗

The IPAB’s mandate expanded significantly when its jurisdiction was extended to cover patents. With effect from April 2, 2007, the IPAB was authorized to hear and adjudicate appeals against most decisions, orders, and directions issued by the Controller of Patents under the Patents Act, 1970. This was a major shift.

Crucially, all patent-related appeals that were pending before various High Courts at that time were transferred to the IPAB by notification. This transfer was not optional – it was a statutory redirection that cleared the High Court dockets of pending IP matters and centralized patent appellate review in one specialized forum. As the WIPO Patent Judicial Guide on India notes, both appellate jurisdiction and the original jurisdiction to revoke patents were redirected to the IPAB as a specialized IP tribunal, with the explicit legislative intent of enabling speedier disposal of such matters.

What decisions could be appealed to the IPAB? 🔗

The IPAB had appellate jurisdiction over a wide range of decisions made by the Controller of Patents. These included refusals of patent applications, decisions on grant or amendment of patents, orders on compulsory licensing, decisions on revocation of patents for non-working, restoration of lapsed patents, surrender of patents, and corrections of clerical errors. The IPAB also held exclusive jurisdiction over revocation of patents and rectification of the register – except where revocation arose as a counter-claim in an infringement suit, in which case jurisdiction remained with the High Court.

However, not all patent decisions were appealable. The IPAB (Procedure) Rules, 2003 specifically exempted from appeal any orders related to inventions concerning defence purposes or atomic energy, as well as orders granting extensions of time under any provision of the Patents Act.

The dual composition of IPAB benches 🔗

One of the IPAB’s defining structural features was the composition of its benches. Each bench comprised a Judicial Member and a Technical Member. This dual structure was central to the IPAB’s purpose. A judicial member brought legal expertise – ensuring procedural fairness, correct application of statutory provisions, and adherence to principles of natural justice. A technical member brought domain knowledge – the ability to evaluate whether a claimed invention was genuinely novel, whether prior art existed, and whether technical arguments made by parties were scientifically sound.

This combination aimed to address a fundamental weakness of the High Court system for patent disputes: that generalist judges, however capable, may not be best placed to assess whether a pharmaceutical compound represents a genuine inventive step or merely an incremental modification. The bench composition was intended to make appellate decisions more technically credible, not just legally sound.

Role in shaping India’s patent law jurisprudence 🔗

During its operational years, the IPAB played a pivotal role in developing consistent, specialized precedents in Indian patent law. One of its most significant contributions was in interpreting Section 3(d) of the Patents Act, 1970 – a provision unique to India that prevents patenting of new forms of known substances unless they demonstrate enhanced efficacy. The IPAB, along with the Indian Patent Office, applied this provision in the landmark Novartis case, where the patent application for the beta crystalline form of imatinib mesylate was rejected on the grounds that it failed to show enhanced efficacy over the known substance. This position was ultimately upheld by the Supreme Court of India in 2013.

By handling these cases with both legal and technical depth, the IPAB contributed to building a body of IP jurisprudence that balanced India’s obligations under the TRIPS Agreement with national priorities around public health and access to medicines. Its decisions on patent opposition, revocation, and compulsory licensing helped standardize how these proceedings were conducted across the country.

Procedural framework and timelines 🔗

Appeals to the IPAB were governed by the Intellectual Property Appellate Board (Procedure) Rules, 2003. Any appeal from a decision of the Controller of Patents had to be filed within three months of the date of the decision, order, or direction, unless the IPAB permitted a further extension. Appeals had to be submitted in the prescribed format, accompanied by the appropriate fees and supporting documents.

The IPAB also retained discretionary power to hear transferred cases either afresh or from the stage at which they were pending before the High Court. This flexibility was important for managing the volume of transferred appeals and ensuring continuity in proceedings.

Abolition of the IPAB in 2021 🔗

Despite its promise, the IPAB faced persistent criticism over the years. Chronic delays in appointing members and chairpersons, questions about technical qualifications, and mounting case backlogs meant that the objective of speedier disposal was not consistently achieved. On April 4, 2021, the President of India promulgated the Tribunals Reforms (Rationalisation and Conditions of Service) Ordinance, 2021, which abolished the IPAB along with several other tribunals. Its functions – including patent appeals and revocation petitions – were transferred back to the respective High Courts.

As a result, Section 116 of the Patents Act (which established the Appellate Board) was omitted, and Section 117A was amended to direct appeals to the High Court. The wheel had turned full circle. While many legal experts and IP practitioners had hoped for a reinvigorated IPAB rather than its abolition – particularly given rising IP filing numbers – the government’s decision was driven by the assessment that the tribunal’s objectives were not being met in practice.

Why the IPAB still matters for law students 🔗

Even though the IPAB no longer exists, its study remains essential for anyone learning Indian patent law. The IPAB’s jurisdiction, procedural rules, structural design, and landmark rulings are deeply embedded in the academic and professional understanding of how IP appellate mechanisms are supposed to function. Exam questions, case studies, and legal arguments continue to reference IPAB-era precedents. More importantly, the policy debates around the IPAB – whether India needs specialized IP courts, how to balance legal expertise with technical knowledge in appellate review – are very much alive today, with calls for dedicated IP benches in High Courts still ongoing.

Understanding the IPAB also gives students a clearer picture of India’s evolving approach to intellectual property governance: from a colonial-era framework, through post-TRIPS reforms, to the specialist tribunal experiment, and now back to High Court-led adjudication with demands for greater specialization. That arc is the story of Indian IP law itself.

What do you think? Given that the IPAB was abolished partly because of administrative inefficiencies rather than flaws in its design, should India consider re-establishing a specialized IP tribunal with stronger institutional safeguards? And with patent disputes growing more technically complex, is a generalist High Court bench – even a designated IP bench – truly sufficient to deliver technically credible appellate decisions?

References

1. https://ipindia.gov.in/writereaddata/Portal/ev/sections-index.html
2. https://dipp.gov.in/about-us/statutory-bodies/intellectual-property-appellate-board
3. https://www.rkdewan.com/articles/intellectual-property-appellate-board-ipab/
4. https://www.wipo.int/patent-judicial-guide/en/full-guide/india
5. https://www.drugpatentwatch.com/blog/indian-pharmaceutical-patent-prosecution-the-changing-role-of-section-3d/
6. https://www.mondaq.com/india/trademark/611548/the-intellectual-property-appellate-board-power-constitution
7. https://www.mondaq.com/india/trademark/1086002/curtains-for-the-intellectual-property-appellate-board-ipab-end-of-a-possible-game-changer
8. https://thelawcodes.com/article/appeals-under-patent-law/